dRAST
Commercial- Indications
- Sepsis
Company intelligence / Profile preview
QuantaMatrix
Seoul, Seoul, South Koreaquantamatrix.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
QuantaMatrix has commercialized rapid antimicrobial susceptibility testing platforms for sepsis diagnosis. Its dRAST system delivers results from positive blood cultures in as little as 4 hours, while the new uRAST platform can provide all-in-one AST results within 13 hours of blood sampling—significantly faster than conventional methods that take several days. These technologies are designed to optimize antibiotic selection and combat antimicrobial resistance.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceDiagnostic test
- Industry
- Molecular Diagnostics
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
admed laboratory and other clinical laboratories in Europe and Asia have adopted QuantaMatrix’s solutions for routine clinical use.Distribution network spans Europe, Middle East, Africa.
Beyond the preview
Go deeper on QuantaMatrix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QuantaMatrix.